Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 ...

Return on investment - most recent fiscal year 16.16 ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cipla's stock is priced at Rs 1472.4, reflecting a slight uptick of 0.07% today, with a six-month return of 3.38%. Cipla is currently trading at Rs 1469.15, showing a slight decline of 0.16% today, ...

Cipla is currently trading at Rs 1470.55, reflecting a notable increase of 2.35% today, with 1-day returns at 2.03%. Cipla is currently valued at Rs 1466.00, marking a 2.04% rise today. The one-year ...

SINGAPORE: Codeine cough syrup made up the majority of illegal health products seized by authorities in 2024, the Health Sciences Authority (HSA) said on Monday (Feb 3). Authorities seized more ...

gonorrhoeae. For the reasons of convenience, cost and ease of administration, oral cefixime 400 mg in a single dose is our first extended cephalosporin of choice. Ceftriaxone 250 mg ...